Response to Comment on: "Alpha-1 antagonist treatment for eyelid retraction in patients with thyroid eye disease - a prospective pilot study"

被引：0
|
作者：
Arnon, Roee [1 ,2 ]
Sagiv, Oded [1 ,3 ]
机构：
[1] Tel Aviv Univ, Goldschleger Eye Inst, Fac Med, Sheba Med Ctr,Tel Hashomer, Tel Aviv, Israel
[2] Assuta Ashdod Hosp, Ophthalmol Dept, Ashdod, Israel
[3] Univ Texas MD Anderson Canc Ctr, Dept Head & Neck Surg, Sect Ophthalmol, Houston, TX 77030 USA
来源：
EYE | 2025年 / 39卷 / 04期
关键词：
D O I：
10.1038/s41433-024-03554-8
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
引用
收藏
页码：801 / 801
页数：1
相关论文
共 50 条
  • [41] An Alpha-1 Antitrypsin Deficiency Screening Study in Patients with Chronic Obstructive Pulmonary Disease, Bronchiectasis, or Asthma in Turkey
    Onur, Seda Tural
    Natoli, Antonino
    Dreger, Bettina
    Arinc, Sibel
    Sarioglu, Nurhan
    Cortuk, Mustafa
    Karadogan, Dilek
    Senyigit, Abdurrahman
    Yildiz, Birsen Pinar
    Kokturk, Nurdan
    Baris, Serap Argun
    Cengiz, Suemeyye Kodalak
    Polatli, Mehmet
    INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2023, 18 : 2785 - 2794
  • [42] Efficacy and safety of glycyrrhizin 2.5% eye drops in the treatment of moderate dry eye disease: results from a prospective, open-label pilot study
    Burillon, Carole
    Chiambaretta, Frederic
    Pisella, Pierre-Jean
    CLINICAL OPHTHALMOLOGY, 2018, 12 : 2629 - 2636
  • [43] Thyroid Eye Disease: Pilot Study Comparison Between Patients in United States-Based and India-Based Practices
    Ramesh, Sathyadeepak
    Naik, Milind
    Watson, Alison
    Zhang, Qiang
    Peskin, Ellen
    Sharpe, James
    Alessi, Kieran
    Hyman, Leslie
    AMERICAN JOURNAL OF OPHTHALMOLOGY, 2024, 264 : 25 - 35
  • [44] Teprotumumab, an insulin-like growth factor-1 receptor antagonist antibody, in the treatment of active thyroid eye disease: a focus on proptosis
    Douglas, Raymond S.
    EYE, 2019, 33 (02) : 183 - 190
  • [45] Teprotumumab, an insulin-like growth factor-1 receptor antagonist antibody, in the treatment of active thyroid eye disease: a focus on proptosis
    Raymond S. Douglas
    Eye, 2019, 33 : 183 - 190
  • [46] Inflammatory Response in Patients With Crohn's Disease Compared With Ulcerative Colitis: Secondary Results of a Prospective Pilot Study
    El-Hussuna, Alaa
    Varghese, Chris
    Bhat, Vivek
    Qvist, Niels
    CROHNS & COLITIS 360, 2022, 4 (04)
  • [47] Effects of Prolastin C (Plasma-Derived Alpha-1 Antitrypsin) on the Acute Inflammatory Response in Patients With ST-Segment Elevation Myocardial Infarction (from the VCU-Alpha 1-RT Pilot Study)
    Abbate, Antonio
    Van Tassell, Benjamin Wallace
    Christopher, Sanah
    Abouzaki, Nayef Antar
    Sonnino, Chiara
    Oddi, Claudia
    Carbone, Salvatore
    Melchior, Ryan David
    Gambill, Michael Lucas
    Roberts, Charlotte Susan
    Kontos, Michael Christopher
    Peberdy, Mary Ann
    Toldo, Stefano
    Vetrovec, George Wayne
    Biondi-Zoccai, Giuseppe
    Dinarello, Charles Anthony
    AMERICAN JOURNAL OF CARDIOLOGY, 2015, 115 (01): : 8 - 12
  • [48] Treatment of patients with severe sepsis using Ulinastatin and Thymosin α1: a prospective, randomized, controlled pilot study
    Chen Hao
    He Ming-yan
    Li Yu-min
    CHINESE MEDICAL JOURNAL, 2009, 122 (08) : 883 - 888
  • [49] Impact of Cannabis Treatment on the Quality of Life, Weight and Clinical Disease Activity in Inflammatory Bowel Disease Patients: A Pilot Prospective Study
    Lahat, Adi
    Lang, Alon
    Ben-Horin, Shomron
    DIGESTION, 2012, 85 (01) : 1 - 8
  • [50] A Novel Ophthalmic Solution Containing Glicopro® Complex for the Treatment of Patients with Dry Eye Disease: Results from a Pilot Study
    Giannaccare, Giuseppe
    Vaccaro, Sabrina
    Borselli, Massimiliano
    Rossi, Costanza
    Carnovale Scalzo, Giovanna
    Scalia, Giovanni
    Di Cesare Mannelli, Lorenzo
    Ghelardini, Carla
    Zerillo, Lucrezia
    Polvere, Immacolata
    Vito, Pasquale
    Zotti, Tiziana
    Stilo, Romania
    Scorcia, Vincenzo
    JOURNAL OF CLINICAL MEDICINE, 2024, 13 (05)
12345